Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 9%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Universal Health Services is supported by a favorable mix of scale, higher-margin behavioral health, and improving operating momentum, with behavioral health generating just over half of consolidated operating income despite acute care contributing over 55% of revenue. The company’s 1Q26 adj. EBITDA rose 8.4% year over year, helped by pricing strength, higher acuity mix, and behavioral health SS revenue up 7.3%, while management expects volume to improve as seasonal headwinds fade and new capacity ramps. Its outlook is further strengthened by continued market share gains in attractive acute-care markets, a persistent multi-year State Directed Payment tailwind, and a disciplined capital plan including $800-900m of share repurchases and earnings-accretive expansion into outpatient care.

Bears say

Universal Health Services is pressured by a difficult mix of regulatory, labor, and market-concentration risks that could undermine both volume and margins, especially if Medicare-for-All, Affordable Care Act changes, or CMS payment actions reduce reimbursement. Its behavioral health business, which generates over 55% of pretax profits, is particularly exposed to tight state budgets, while acute care still represents over 55% of revenue and faces weaker core growth, with 1Q26 acute volumes flat and HIX volumes down 5%. The company also carries headline and operational risk from its September 2020 cyberattack, estimated to have cost $67MM pre-tax, and its heavy concentration in Nevada, Texas, and California leaves results vulnerable to localized weakness.

UHS has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 11 analysts, UHS has a Buy consensus rating as of Oct 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $196.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $196.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.